Fujifilm Ties With U.S. Alzheimer's Consortium To Develop Drug
This article was originally published in PharmAsia News
Executive Summary
Fujifilm Holdings and the U.S. consortium Alzheimer's Disease Cooperative Study have joined in developing the Japan device maker's T-817MA drug through U.S. Phase II trials and beyond starting in January.